Clinical Trials Directory

Trials / Unknown

UnknownNCT05945082

Fusobacterium Nucleatum at Colorectal Cancer Sites

Presence of Fusobacterium Nucleatum at Colorectal Cancer Sites - Influencing Factors and Screening Possibilities

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Malmö University · Academic / Other
Sex
All
Age
18 Years – 120 Years
Healthy volunteers
Not accepted

Summary

Recent studies suggest an association of periodontitis with an overall increased cancer risk but also with cancer development in specific anatomic regions, such as in the colon. The gut microbiome in general and specifically Fusobacterium nucleatum have been described to likely affect colorectal cancer (CRC) development. The present project intends to evaluate the possible contribution of the oral cavity as a reservoir for dissemination of F.nucleatum to the colon. Additionally, the gut microbiome and dietary intake will be assessed as possible factors influencing colonization of CRC sites with F. nucleatum and an association of F.nucleatum colonization in the colon with parameters in the saliva and serum will be tested. One-hundred-fifty patients diagnosed with CRC will be included; after cancer diagnosis and before starting cancer treatment a periodontal examination will be done and saliva and serum samples and at the time-point of tumor resection a biopsy of the CRC sites will be collected.

Conditions

Interventions

TypeNameDescription
OTHERbiopsybiopsy of a colorectal cancer site

Timeline

Start date
2017-11-29
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2023-07-14
Last updated
2023-07-14

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT05945082. Inclusion in this directory is not an endorsement.